Skip to main content
Log in

Tetanusimpfung — Verträglichkeit und Vermeidung von Nebenreaktionen

Tetanus vaccination — Tolerance and avoidance of adverse reactions

  • Übersicht
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Data collected over a 15-year period concerning the side effects directly reported following administration of Tetanol were evaluated and it was found that the tetanus vaccination exhibited an extremely high degree of tolerance, with only 27 cases of side effects for 1 million doses.

In over 80% of those cases with side effects the intolerance took the form of a painful reddening and/or swelling at the site of injection. This reaction to the vaccination, though not uncommon, was thus greater than is to be expected. General reactions, particularly malaise and an increase in body temperature, accounted for 10% of the cases reported; 3% involved skin reactions beyond the injection site. Symptoms involving the cardiac, circulatory, respiratory, locomotor, or nervous system occurred in fewer than 3 cases per 1 million doses, i.e., in fewer than 5% of the reported cases. It proved highly improbable that an allergic-anaphylactic or anaphylactoid reaction was involved and the complete picture of anaphylactic shock was never observed.

Young and middle-aged adults with several tetanus pre-vaccinations accounted for the majority of side effects reported and in most cases hyperimmunization was suspected as a cause. As they were mainly restricted to the site of application and in 75% of cases occurred within 2–48 h, they can be interpreted as type III reactions (Arthus type). Furthermore it can be assumed that other causes of the reactions will have included unintentional intravascular and subcutaneous administration. Finally, one should also allow for the possibility of disease having coincided with the vaccination — especially in those cases where the reaction was not limited to the application site.

More than 90% of all those adverse reactions occurring following a tetanus vaccination could thus be avoided by correct vaccination techniques and detailed vaccination anamnesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Abt W (1980) Unfallanalyse 1980. Schriftreihe des Hauptverbandes der gewerblichen Berufsgenossenschaften e.V., S 61–73

  2. Russel A (1960) Allergy to tetanus toxoid. JAMA 174/9:1220

    Google Scholar 

  3. Baraff L, Cody C, James Ch (1984) DTP — Associated reactions: An analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics 73/1:31–36

    Google Scholar 

  4. Bösel B, Hartung K (Hrsg) (1984) Tetanus. In Praktikum des Infektions- und Impfschutzes, 6. Auflage, Hoffmann, Berlin, S 328–329

    Google Scholar 

  5. Brindle MJ, Twyman DG (1962) Allergic reactions to tetanus toxoid. Brit Med J 1/5285:1116–1117

    Google Scholar 

  6. Brit Med J (1974) Reactions to tetanus toxoid. Brit Med J 1/5897:48

    Google Scholar 

  7. Cockshott WP, Thompson GT, Howlett LJ, Seeley ET (1982) Intramuscular or intralipomatous injections? New Engl J Med 307/6:356–358

    Google Scholar 

  8. David D, Zehntner B (1971) Tetanusimpfung: Nebenwirkungen bei verschiedenen Impflokalisationen und Modus. Schweiz Med Wochenschr 101/29:1055–1057

    Google Scholar 

  9. Dengler R (1978) Zentralnervöse Komplikationen nach Tetanusauffrischimpfung. Münch Med Wochenschr 120/20:707–708

    Google Scholar 

  10. Dieckhöfer K, Scholl R, Wolf R (1978) Neurologische Störungen nach Tetanusimpfung. Med Welt 29/44:1710–1712

    Google Scholar 

  11. Edsall G, Elliot M, Peebles T, Levine L, Eldred M (1967) Excessive use of tetanus toxoid boosters. JAMA 202/1:111–113

    Google Scholar 

  12. Ehrengut W (1970) Reaktionen der Wundstarrkrampfimpfung. Dtsch Med Wochenschr 95/35:1799–1800

    Google Scholar 

  13. Fardon D (1967) Unusual reactions to tetanus toxoid. JAMA 199/2:125–126

    Google Scholar 

  14. Fenichel GM (1983) Neurologic complications of tetanus toxoid. Arch Neurol Vol 40:390

    Google Scholar 

  15. Goto N, Akama K (1982) Histopathological studies of reactions in mice injected with aluminium — adsorbed tetanus toxoid. Microbiol Immunol 26/12:1121–1132

    Google Scholar 

  16. Holzner A (1978) Immunstatus nach Tetanus-Impfung. Fortschr Med 96/13:680–683

    Google Scholar 

  17. Hopf H-Ch (1980) Guillain-Barré-Syndrom nach Tetanus-Schutz-Impfung. Akt Neurol 7:195–200

    Google Scholar 

  18. Jacobs R, Lowe R, Lanier B (1982) Adverse reactions to tetanus toxoid. JAMA 247/1:40–42

    Google Scholar 

  19. Kittler F, Schmith P, Hefley B, Cazort A (1966) Reactions to tetanus toxoid. Southern Med J 59:149–153

    Google Scholar 

  20. König W, Bohn A (1983) Allergie-Anaphylaxie. In: Vorlaender K-O (Hrsg) Immunologie. 2. Auflage, Thieme, Stuttgart New York, S 146

    Google Scholar 

  21. Kuhlwein A, Küchmeister B (1983) Tetanus-Hyperimmunisierungsphänomen und Wehrdienstfähigkeit. Wehrmed Monatsschr 8:320–325

    Google Scholar 

  22. Levine L, Ipsen J, McComb J (1961) Adult immunization-preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adults use. Am J Hyg 73:20–35

    Google Scholar 

  23. McComb J, Levine L (1961) Adult immunization — II. Dosage reduction as a solution to increasing reactions to tetanus toxoid. New Engl J Med 265/23:1152–1153

    Google Scholar 

  24. Myers MG, Beckman ChW, Vosdingh RA, Hankins WA (1982) Primary immunization with tetanus and diphtheria toxoids. JAMA 248/19:2478–2480

    Google Scholar 

  25. Peebles TC, Levine L, Eldred MC, Edsal G (1969) Tetanustoxoid emergency boosters. New Engl J Med 280/11:575–581

    Google Scholar 

  26. Quast U, Werb M (1980) Arzneimittelsicherheit durch Erfassung von Nebenreaktionen mit Computer. Diagn Intensivther 5:76–79

    Google Scholar 

  27. Quast U, Hennessen W, Widmark RM (1979) Mono- and polyneuritis after tetanus vaccination. Develop biol Standard 43:25–32

    Google Scholar 

  28. Reinstein L, Pargament JM, Goodman JS (1982) Peripheral neuropathy after multiple tetanus toxoid injections. Arch Phys Med Rehabil 63:332–334

    Google Scholar 

  29. Relihan M (1969) Reactions to tetanus toxoid. J Irish Med Ass 62/390:430–434

    Google Scholar 

  30. Schlenska GK (1977) Unusual neurological complications following tetanus toxoid administration. J Neurol 576:1–4

    Google Scholar 

  31. Schneider CH (1964) Reactions to tetanus toxoid: A report of five cases. Med J Aust 2:303–305

    Google Scholar 

  32. Slater DN, Underwood JCE, Durrant TE, Gray T, Hopper IP (1982) Aluminum hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis. Brit J Dermat 107:103–108

    Google Scholar 

  33. Spiess H (1973) Anaphylaktische Reaktionen nach aktiver Tetanus-Immunisierung. Dtsch Med Wochenschr 98/13:682

    Google Scholar 

  34. Staak M, Wirth E (1973) Zur Problematik anaphylaktischer Reaktionen nach aktiver Tetanus-Immunisierung. Dtsch Med Wochenschr 98/3:110–111

    Google Scholar 

  35. Staak M (1973) Stellungnahme zu: Anaphylaktische Reaktionen nach aktiver Tetanus-Immunisierung von Spiess. Dtsch Med Wochenschr 98/13:682

    Google Scholar 

  36. Wegmann A, Heiz R (1979) Lokale Reaktionen nach wiederholten Tetanusimpfungen. Schweiz Med Wochenschr 109/38:1409–1410

    Google Scholar 

  37. Zaloga GP, Chernow B (1982) Life-threatening anaphylactic reactions to tetanus toxoid. Ann Allergy 49:107–108

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korger, G., Quast, U. & Dechert, G. Tetanusimpfung — Verträglichkeit und Vermeidung von Nebenreaktionen. Klin Wochenschr 64, 767–775 (1986). https://doi.org/10.1007/BF01732184

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01732184

Key words

Navigation